Novel biomarker candidates for gastric cancer.
暂无分享,去创建一个
[1] Cancer drug trials show modest benefit: drugs target liver, gastric, head and neck cancers. , 2007, JAMA.
[2] J. Ajani,et al. Loss of Krüppel-Like Factor 4 Expression Contributes to Sp1 Overexpression and Human Gastric Cancer Development and Progression , 2006, Clinical Cancer Research.
[3] Steven Gallinger,et al. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. , 2007, Cancer research.
[4] John R. Mackey,et al. Gastric Adenocarcinoma: Review and Considerations for Future Directions , 2005, Annals of surgery.
[5] Tsung-Teh Wu,et al. Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. , 2005, Cancer research.
[6] O. Yokosuka,et al. Analysis of genes upregulated by the demethylating agent 5‐aza‐2′‐deoxycytidine in gastric cancer cell lines , 2006, International journal of cancer.
[7] Sheng‐Chung Lee,et al. CDK-dependent Activation of Poly(ADP-ribose) Polymerase Member 10 (PARP10)* , 2006, Journal of Biological Chemistry.
[8] M. Choi,et al. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. , 2007, The Journal of surgical research.
[9] F. Hsieh,et al. Clinicopathologic Correlation of Up-regulated Genes Identified Using cDNA Microarray and Real-time Reverse Transcription-PCR in Human Colorectal Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[10] S. Kitano,et al. Multivariate prognostic study on large gastric cancer , 2007, Journal of surgical oncology.
[11] Johan Ingvarsson,et al. Identification of Protein Expression Signatures Associated with Helicobacter pylori Infection and Gastric Adenocarcinoma Using Recombinant Antibody Microarrays* , 2006, Molecular & Cellular Proteomics.
[12] J. Roberts,et al. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. , 2007, The Journal of urology.
[13] C. Moskaluk,et al. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. , 2005, Neoplasia.
[14] D. Sidransky,et al. PGP9.5 methylation in diffuse-type gastric cancer. , 2006, Cancer research.
[15] Woo Ick Yang,et al. Molecular basis of the differences between normal and tumor tissues of gastric cancer. , 2007, Biochimica et biophysica acta.
[16] Joachim Diebold,et al. Functional epigenomics identifies genes frequently silenced in prostate cancer. , 2005, Cancer research.
[17] M. Israel,et al. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. , 1988, Cancer research.
[18] E. El-Omar,et al. Cellular and molecular aspects of gastric cancer. , 2006, World journal of gastroenterology.
[19] T. H. Bø,et al. New feature subset selection procedures for classification of expression profiles , 2002, Genome Biology.
[20] Hsuan-Cheng Huang,et al. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. , 2006, Journal of proteome research.
[21] W. Park,et al. Genetic and epigenetic analysis of the KLF4 gene in gastric cancer , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[22] Graziano Pesole,et al. On the statistical assessment of classifiers using DNA microarray data , 2006, BMC Bioinformatics.
[23] M. Suetsugi,et al. Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues. , 2005, The Journal of clinical endocrinology and metabolism.
[24] H. Randeva,et al. Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma , 2006, Journal of Clinical Pathology.